Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 Result [Yahoo! Finance]
Bionano Genomics, Inc. (BNGO)
Last bionano genomics, inc. earnings: 8/8 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2025 revenue is $6.87 million, and the earnings are expected to come in at -$1.91 per share. The full year 2025's revenue is expected to be $28.14 million, and the earnings are expected to be -$6.85 per share. More detailed estimate data can be found on the Forecast page Bionano Genomics Inc ( NASDAQ:BNGO ) Estimates Trends Warning! GuruFocus has detected 5 Warning Signs with BNGO. Is BNGO fairly valued? Test your thesis with our free DCF calculator. Revenue estimates for Bionano Genomics Inc ( NASDAQ:BNGO ) have declined from $28.98 million to $28.14 million for the full year 2025 and declined from $35.38 million to $35.04 million for 2026 over the past 90 days. Earnings estimates have increased from -$7.71 per share to -$6.85 per share for the full year 2025 and increased from -$4.41 per share to -$3.95 per share for 2026 over the past 90 days. Bionano Genomics Inc ( NASDAQ:BNGO ) Reported History In the previous quarter of 2025-06-30, Biona
Show less
Read more
Impact Snapshot
Event Time:
BNGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNGO alerts
High impacting Bionano Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
BNGO
News
- Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies [Yahoo! Finance]Yahoo! Finance
- Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic MalignanciesGlobeNewswire
- Bionano Genomics (NASDAQ:BNGO) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Bionano Genomics (NASDAQ:BNGO) had its "sell (e)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute LeukemiaGlobeNewswire
BNGO
Analyst Actions
- 11/24/25 - HC Wainwright
BNGO
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- BNGO's page on the SEC website